Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 21 recruiting now later-stage tilt

Postpartum Depression: later-stage trial registry

21 of 48 indexed Postpartum Depression trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #297 of 28,707 conditions by registered trial count.

48 US clinical trials · 21 currently recruiting · #297 of 28,707 conditions by registered trial count

Postpartum Depression: 48 US clinical trials tracked, 21 recruiting.

Postpartum Depression is the subject of 48 registered US clinical trials on ClinicalTrials.gov, 21 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Women and Infants Hospital of Rhode Island, running 3 of these trials.

Enrollment posture brief

Registry condition postpartum-depression

OPEN 21 | RECR 44% | LATE 5 | EARLY 3 | RANK #297 | SPON 3

Nearest open-share peer: Acute Respiratory Distress Syndrome (44% recruiting · 32 trials)

Gastric Adenocarcinoma54.2%Lung Non-Small Cell Carcinom47.9%Postpartum Depression (this)44%Brain Cancer41.7%Depressive Disorder31.3%
Open-enrollment share among volume-matched conditions near Postpartum Depression

Postpartum Depression lists 21 open slots (44% of 48 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Postpartum Depression on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Postpartum Depression is recruiting above its size-band peers.

    21 of 48 indexed trials (43.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Postpartum Depression trials is spread across many organizations.

    Women and Infants Hospital of Rhode Island accounts for 3 of 48 trials (6.3%). 36 distinct sponsors appear on at least one study for this condition label.

  3. Typical Postpartum Depression enrolment sits around 108 participants.

    Median target enrolment is 108 among the 48 trials that report a genuine target (sentinel values excluded). 24 of those (50%) plan for fewer than 100 participants.

  4. Postpartum Depression research is mostly interventional.

    42 interventional and 6 observational studies make up this index (87.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 22Phase 33Phase 42

Open and recent trials

48 total, page 1 of 1

RECRUITING NA 2,320 participants

The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention

Michigan State University

NCT05700760

RECRUITING NA 900 participants

In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression

University of Denver

NCT05766475

RECRUITING NA 750 participants

Parenting Skills Group for Mothers With Postpartum Depression

University of Colorado, Denver

NCT05772897

RECRUITING NA 750 participants

Fresh RX: NHS 2020

Washington University School of Medicine

NCT04845230

RECRUITING NA 500 participants

Maternal Stress on Human Milk and Infant Outcomes

University of Idaho

NCT04821544

RECRUITING NA 400 participants

Rosie the Chatbot: Leveraging Automated and Personalized Health Information Communication

University of Maryland, College Park

NCT06053515

RECRUITING NA 384 participants

The Mom and Infant Outcomes (MOMI) Study

Ohio State University

NCT06277661

RECRUITING NA 342 participants

Improving Maternal Sleep and Mental Health

University of Colorado, Colorado Springs

NCT06544941

RECRUITING NA 300 participants

Preventing Postpartum Depression in Immigrant Latinas

Northwestern University

NCT05873569

RECRUITING 200 participants

A Long-Term Study of Patient-Reported Changes in Postpartum Depression Symptoms in People Starting Zuranolone

Biogen

NCT07398469

RECRUITING NA 120 participants

Maternal Mental Health Access - MaMa

University of Utah

NCT06049433

RECRUITING NA 117 participants

ROSE in Sunset Park

NYU Langone Health

NCT04940585

RECRUITING NA 75 participants

Understanding the Role of Doulas in Supporting People With PMADs

University of Montana

NCT05763537

RECRUITING NA 72 participants

OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression

Hackensack Meridian Health

NCT06991166

RECRUITING NA 60 participants

Engage & Connect: A Psychotherapy for Postpartum Depression

Weill Medical College of Cornell University

NCT05585164

RECRUITING NA 55 participants

The Dream Team: Testing Implementation of a Sleep Intervention for Perinatal Women Delivered by Direct Care Workers

Rhode Island Hospital

NCT06737055

RECRUITING Phase 1 50 participants

Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery

Grace Lim, MD, MS

NCT06767566

RECRUITING NA 40 participants

Accelerated iTBS for Post Partum Depression

Medical University of South Carolina

NCT03417960

RECRUITING NA 40 participants

Virtual Patient Navigation During a Pandemic

Children's Hospital of Philadelphia

NCT06208852

RECRUITING NA 24 participants

Accelerated TMS for Perinatal Depression

Brigham and Women's Hospital

NCT06968390

RECRUITING NA 20 participants

Postpartum Care in the NICU (PeliCaN) Transitions

University of Pennsylvania

NCT06521398

ACTIVE NOT RECRUITING NA 10,473 participants

Improving Maternal Mental Health & SUD Screening and Treatment

Medical University of South Carolina

NCT05764213

ACTIVE NOT RECRUITING Phase 3 600 participants

mHealth Mindfulness Intervention for Pregnant Black and Latina Women at Risk of Postpartum Depression

Kaiser Permanente

NCT05186272

ACTIVE NOT RECRUITING NA 90 participants

Feasibility & Acceptability of App-based Cognitive Behavioral Therapy for Postpartum Depression Prevention

Women and Infants Hospital of Rhode Island

NCT06365645

ACTIVE NOT RECRUITING NA 84 participants

The Maternal Well-Being Study

Texas Tech University Health Sciences Center

NCT05484999

ACTIVE NOT RECRUITING NA 62 participants

Prenatal Yoga to Prevent Postpartum Depression

Henry Ford Health System

NCT06004232

COMPLETED NA 874 participants

Comparing the Effectiveness of Clinicians and Paraprofessionals to Reduce Disparities in Perinatal Depression

Northwestern University

NCT02979444

COMPLETED 300 participants

A Study of Pregnant and Postpartum Women With and Without Mood Disorders

Johns Hopkins University

NCT03615794

COMPLETED NA 299 participants

Healthy Lifestyle Intervention for High-Risk Minority Pregnant Women

Ohio State University

NCT03416010

COMPLETED Phase 3 276 participants

A Study to Evaluate SAGE-217 in Participants With Severe Postpartum Depression

Biogen

NCT02978326

COMPLETED NA 250 participants

Interpersonal Therapy-Based Treatment to Prevent Postpartum Depression in Adolescent Mothers

Women and Infants Hospital of Rhode Island

NCT01482832

COMPLETED NA 220 participants

Improving Health Outcomes and Equity by Targeting Postpartum Mothers at Highest Risk

University of Pennsylvania

NCT06276647

COMPLETED NA 208 participants

The Impact of a Newborn Behavioral Intervention on the Mental Health of Mothers With Late Pre-Term Infants

Brigham and Women's Hospital

NCT03836430

COMPLETED NA 162 participants

Postpartum Visit Timing and the Effect on Visit Attendance

Women and Infants Hospital of Rhode Island

NCT05399784

COMPLETED Phase 4 160 participants

Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery

Icahn School of Medicine at Mount Sinai

NCT04017442

COMPLETED Phase 3 108 participants

A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)

Supernus Pharmaceuticals

NCT02942017

COMPLETED NA 95 participants

Social Media-Based Parenting Program for Women With Postpartum Depressive Symptoms: Impact on Child Development

Children's Hospital of Philadelphia

NCT05400161

COMPLETED Phase 2 93 participants

A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression

DuKang Pharmaceuticals

NCT06285916

COMPLETED 80 participants

Neuroimaging Epigenetics of Prospective Postpartum Depression Biomarkers

Johns Hopkins University

NCT03638687

COMPLETED 75 participants

Postpartum Thyroid Measures and Mood

Oklahoma State University Center for Health Sciences

NCT00565032

COMPLETED Phase 2 74 participants

The Role of Hormones in Postpartum Mood Disorders

National Institute of Mental Health (NIMH)

NCT00001481

COMPLETED NA 60 participants

Social Circumstances, Parenting Techniques, and Infant Development

New York State Psychiatric Institute

NCT02121496

COMPLETED Phase 4 52 participants

A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting

Supernus Pharmaceuticals

NCT05059600

COMPLETED NA 49 participants

Pilot Trial of CenteringPregnancy With Mindfulness Skills

University of California, San Francisco

NCT01646463

COMPLETED NA 33 participants

Does Enhancing Maternal Peer Interactions Decrease Rates of Postpartum Depression?

Milton S. Hershey Medical Center

NCT03793569

COMPLETED 17 participants

Determining Relationships Among Maternity Stress & Sleep

University of North Carolina, Chapel Hill

NCT02133963

COMPLETED NA 17 participants

A Postpartum Adaptation Study of the Connecting and Reflecting Experience Parenting Program

Montefiore Medical Center

NCT06042166

COMPLETED 10 participants

Dynamic Neural Mechanisms of Brexanolone-induced Antidepressant Effects in Postpartum Depression

University of North Carolina, Chapel Hill

NCT05543746

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 2
Phase 3 3
Phase 4 2

Named interventions

Most-linked intervention names on Postpartum Depression records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
3 trials
Connecting and Reflecting Experience (CARE) Program Behavioral
1 trials
NORA520 Dose 2 Drug
1 trials
NORA520 Dose 1 Drug
1 trials
HOME Behavioral
1 trials
Social Media-Based Parenting Program Behavioral
1 trials
MoodGym Behavioral
1 trials
Interpersonal therapy-based treatment Behavioral
1 trials

US sites by state

Facility locations filed on Postpartum Depression trials. A trial with sites in several states counts in each.

New York 10 trials
Pennsylvania 6 trials
California 6 trials
Maryland 5 trials
Rhode Island 4 trials
Massachusetts 4 trials
Illinois 4 trials
Florida 4 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Postpartum Depression page

48 registered trials, 21 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Postpartum Depression condition card totals 48 registered trials; most-linked intervention Placebo; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.